Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2020 1
2021 7
2022 6
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

12 results

Results by year

Filters applied: . Clear all
Page 1
Immunotherapy for cholangiocarcinoma: a 2021 update.
Charalampakis N, Papageorgiou G, Tsakatikas S, Fioretzaki R, Kole C, Kykalos S, Tolia M, Schizas D. Charalampakis N, et al. Among authors: tsakatikas s. Immunotherapy. 2021 Sep;13(13):1113-1134. doi: 10.2217/imt-2021-0126. Epub 2021 Jun 30. Immunotherapy. 2021. PMID: 34190581 Review.
Immunotherapy for gastric cancer: a 2021 update.
Kole C, Charalampakis N, Tsakatikas S, Kouris NI, Papaxoinis G, Karamouzis MV, Koumarianou A, Schizas D. Kole C, et al. Among authors: tsakatikas s. Immunotherapy. 2022 Jan;14(1):41-64. doi: 10.2217/imt-2021-0103. Epub 2021 Nov 17. Immunotherapy. 2022. PMID: 34784774 Review.
Immunotherapy for Hepatocellular Carcinoma: A 2021 Update.
Kole C, Charalampakis N, Tsakatikas S, Vailas M, Moris D, Gkotsis E, Kykalos S, Karamouzis MV, Schizas D. Kole C, et al. Among authors: tsakatikas s. Cancers (Basel). 2020 Oct 4;12(10):2859. doi: 10.3390/cancers12102859. Cancers (Basel). 2020. PMID: 33020428 Free PMC article. Review.
Immunotherapy for gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs): a 2021 update.
Kole C, Charalampakis N, Vailas M, Tolia M, Sotiropoulou M, Tsakatikas S, Kouris NI, Tsoli M, Koumarianou A, Karamouzis MV, Schizas D. Kole C, et al. Among authors: tsakatikas s. Cancer Immunol Immunother. 2022 Apr;71(4):761-768. doi: 10.1007/s00262-021-03046-8. Epub 2021 Sep 1. Cancer Immunol Immunother. 2022. PMID: 34471940 Review.
Radiotherapy and Breast Reconstruction: What Is the Ideal Timing? A Narrative Review.
Letsiou E, Tsakatikas S, Vakis G, Tsapakidis K, Charalampakis N, Diamantis A, Poultsidi A, Michelakis D, de Bree E, Mauri D, Tsoukalas N, Antoniades C, Tolia M. Letsiou E, et al. Among authors: tsakatikas s. Rev Recent Clin Trials. 2022;17(2):73-85. doi: 10.2174/1574887117666220314161609. Rev Recent Clin Trials. 2022. PMID: 35289255 Review.
Trimodality treatment in gastric and gastroesophageal junction cancers: Current approach and future perspectives.
Charalampakis N, Tsakatikas S, Schizas D, Kykalos S, Tolia M, Fioretzaki R, Papageorgiou G, Katsaros I, Abdelhakeem AAF, Sewastjanow-Silva M, Rogers JE, Ajani JA. Charalampakis N, et al. Among authors: tsakatikas s. World J Gastrointest Oncol. 2022 Jan 15;14(1):181-202. doi: 10.4251/wjgo.v14.i1.181. World J Gastrointest Oncol. 2022. PMID: 35116110 Free PMC article. Review.
Central neurotoxicity induced by trastuzumab emtansine (T-DM1): a case report.
Papageorgiou GI, Symeonidis DG, Tsakatikas SA, Liatsos AD, Douglas KAA, Douglas VP, Moschos MM, Kosmas C. Papageorgiou GI, et al. Among authors: tsakatikas sa. Anticancer Drugs. 2021 Nov 1;32(10):1146-1149. doi: 10.1097/CAD.0000000000001117. Anticancer Drugs. 2021. PMID: 34232951
12 results